Nov 05, 2020 / 01:30PM GMT
Operator
Good day, and welcome to the Bristol-Myers Squibb 2020 Third Quarter Results Conference Call. Today's conference is being recorded. At this time, I would like to turn the conference over to Mr. Tim Power, Vice President, Investor Relations. Please go ahead, sir.
Timothy Power - Bristol-Myers Squibb Company - VP & Head of IR
Thanks, Kevin, and good morning, everyone. Thanks for joining us this morning for our third quarter 2020 earnings call.
Joining me this morning with prepared remarks are Giovanni Caforio, our Board Chair and Chief Executive Officer; and David Elkins, our Chief Financial Officer. And also participating in today's call are Chris Boerner, our Chief Commercialization Officer; Nadim Ahmed, President, Hematology; and Samit Hirawat, our Chief Medical Officer and Head of Global Drug Development. As you note, we've posted slides to bms.com that you can follow along with Giovanni and David's remarks.
And before we get going, I'll read our forward-looking statements. During this call, we'll make statements about the company's
Q3 2020 Bristol-Myers Squibb Co Earnings Call Transcript
Nov 05, 2020
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers